Improvements in survival of gynaecological cancer in the Anglia region of England: Are these an effect of centralisation of care and use of multidisciplinary management?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 119, Issue 2, 2012, Pages 160-165

  Crawford, R ^a   Greenberg, D ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b Eastern Cancer Registration and Information Centre (ECRIC)   (United Kingdom)

Author keywords

Centralised care; gynaecological cancer; multidisciplinary team management; survival rates

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CENTRALIZATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; UNITED KINGDOM;

ENGLAND; FEMALE; GENITAL NEOPLASMS, FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; PATIENT CARE TEAM; REGIONAL MEDICAL PROGRAMS; SURVIVAL RATE;

EID: 83655163978     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.02961.x     Document Type: Article

References (19)

1. A policy framework for commissioning cancer services: a report by the expert advisory group on cancer to the chief medical officers of England and Wales. []. Last accessed 19 January 2011.
2. The NHS cancer plan: a plan for investment, a plan for reform (2000) department of health. []. Last accessed 19 January 2011.
3. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al., Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784-96. (Pubitemid 47321601)
4. Guidance on commissioning cancer services: improving outcomes in gynaecological cancers-the manual·1999. []. Last accessed 19 January 2011.
5. Münstedt K, von Georgi R, Misselwitz B, Zygmunt M, Stillger R, Künzela W,. Centralizing surgery for gynecologic oncology-a strategy assuring better quality treatment? Gynecol Oncol 2003; 89: 4-8.
6. Bilimoria K, Bentrem D, Feinglass J, Stewart AK, Winchester DP, Talamonti MS, et al., Directing surgical quality improvement initiatives:comparison of perioperative mortality and long-term. Survival for cancer surgery. JCO 2008; 26: 1-8.
7. Department of health. Referral guidelines for suspected cancer. 2000 superseded by NICE guidance 27 []. Last accessed 19 January 2011.
8. Sobin LH, Wittekind C,. TNM Classification of Malignant Tumours, 5th edn. New York: Wiley-Liss, 1997.
9. Cox DR,. Regression models and life-tables. JR Stat Soc B 1972; 34: 187-220.
10. Swerdlow AJ, Dos SSI, Doll R,. Cancer Incidence and Mortality in England and Wales: Trends and Risk Factors. Oxford: Oxford University Press, 2001. pp. 9-10.
11. Sala E, Crawford R, Senior E, Shaw A, Simcock B, Vrotsou K, et al., Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 2009; 19: 141-6.
12. Winter-Roach BA, Kitchener HC, Dickinson HO,. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2009; Issue 3: CD004706. DOI: 10.1002/14651858.CD004706.pub3.
13. Hamilton W, Peters TJ, Bankhead C, Sharp D,. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ 2009; 339: b2998.
14. International Collaborative Ovarian Neoplasm Group. Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet 2002; 360: 505-15.
15. van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, et al., The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the European organization for research and treatment of cancer. N Engl J Med 1995; 332: 629-34.
16. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK,. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373: 125-36.
17. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al., Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post Operative radiation therapy in endometrial carcinoma. Lancet 2000; 355: 1404-11. (Pubitemid 30215963)
18. Tierney JF, Vale C, Symonds P,. Concomitant and neoadjuvant chemotherapy for cervical cancer. Clin Oncol 2008; 20: 401-16.
19. Rachet B, Maringe C, Nur U, Quaresma M, Shah A, Woods LM, et al., Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009; 10: 351-69.